Abstract
Numerous studies have demonstrated changes in receptor number, protein concentration, or mRNA levels and have proposed that these subcellular changes produce physiologic effects. To date, no adequate mathematical analysis has been available to provide a framework for interpretation of such data. In the present study we have combined measurements of angiotensin receptor protein levels with the development of a mathematical model that includes two receptors with opposing actions for a single ligand. This model was used to quantify the net, physiologic response of each receptor population to ANG II stimulation and the effect of altering the expression of receptor populations by a physiologic stimulus. Altered sodium intake was used as the physiologic stimulus and quantification of Western blot analysis and revealed that high sodium diet significantly suppressed AT1 receptor protein in the adrenal gland and aorta and augmented AT2 receptor protein in the aorta. A high sodium diet did not significantly alter AT2 receptor protein in the adrenal gland. Modeling the measured sodium-induced changes in receptor concentration demonstrated that small, subcellular changes in receptor concentration can have a large impact on the net physiologic effect. This model for dual receptor–single ligand interactions should be amenable for other systems. © 2000 Biomedical Engineering Society.
PAC00: 8710+e, 8714Ee
Similar content being viewed by others
REFERENCES
Aguilera, G., A. Schirar, A. Baukal, and K. J. Catt. Angiotensin II Receptors: Properties and regulation in adrenal glomerulosa cells. Circ.Res. 46:I118–I127, 1980.
Bowman, W. C., and M. J. Rand. Textbook of Pharmacology, 2nd ed., Blackwell Scientific, 1980: 13–39.43.
Dahlof, B.. Effect of angiotensin II blockade on cardiac hy-pertrophy and remodeling: a review. J.Hum.Hypertens. 9:S37–S44, 1995.
Dudley, D. T., S. E. Hubbell, and R. M. Summerfelt. Characterization of angiotensin II (AT2) binding sites in R3T3 cells. Mol.Pharmacol. 40:360–367, 1991.
Ferrario, C. M., and J. M. Flack. Pathologic consequences of increased angiotensin II activity. Cardiovasc.Drugs Therapy 10:511–518, 1996.
Fyhrquist, F., K. Metsarinne, and I. Tikkanen. Role of angio-tensin II in blood pressure regulation and in the pathophysiology of cardiovascular disorders. J.Hum.Hypertens. 9:S19–S24, 1995.
Garg, R., and S. Yusuf. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. J.Am.Med.Assoc. 273:1450–1456, 1995.
Griffin, S., W. Brown, F. MacPherson, J. McGrath, V. Wilson, N. Korsgaard, M. Mulvany, and A. Lever. Angiotensin II causes vascular hypertrophy in part by non-pressor mechanism. Hypertension (Dallas) 17:626–635, 1991.
Hernandez, I., A. W. Cowley, Jr., J. H. Lombard, and A. S. Greene. Salt intake and angiotensin II alter microvessel density in the cremaster muscle of normal rats. Am.J.Physiol. 263:H664–H667, 1992.
Ichiki, T., P. A. Labosky, C. Shiota, S. Okuyama, Y. Imagawa, A. Fogo, F. Niimura, I. Ichikawa, B. L. M. Hogan, and T. Inagami. Effects on blood pressure and exploratory behav-ior of mice lacking angiotensin II type 2 receptor. Nature (London) 377:748–750, 1995.
Ito, M., M. I. Oliverio, P. J. Mannon, C. F. Best, M. Maeda, O. Smithies, and T. M. Coffman. Regulation of blood pres-sure by the type 1A angiotensin II receptor gene. Proc.Natl.Acad.Sci.USA 92:3521–3525, 1995.
Iwai, N., and T. Inagami. Regulation of the expression of the rat angiotensin II receptor mRNA. Biochem.Biophys.Res.Commun. 182:1094–1099, 1992.
Kitami, Y., T. Okura, K. Marumoto, R. Wakamiya, and K. Hiwada. Differential gene expression and regulation of type-1 angiotensin II receptor subtypes in the rat. Biochem.Biophys.Res.Commun. 188:446–452, 1992.
Kwok, Y. C., and G. J. Moore. Photoaffinity labeling of the rat isolated portal vein: Determination of affinity constants and “spare” receptors for angiotensin II and III. J.Pharma-col.Exp.Ther. 231:137–140, 1984.
Kwok, Y. C., and G. J. Moore. Comparison of angiotensin receptors in isolated smooth muscle tissues by photoaffinity labeling. Eur.J.Pharmacol. 115:53–58, 1985.
Lauffenburger, D. A., and J. J. Linderman. Receptors: Models for Binding, Trafficking, and Signaling, London: Oxford University, 1993: 13–43, 247–251.
Llorens-Cortez, C., B. Greenberg, H. Huang, and P. Corvol. Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis. Hypertension (Dallas) 24:538–548, 1994.
Munzenmaier, D. H., and A. S. Greene. Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension (Dallas) 27:760–765, 1996.
Nora, E. H., D. H. Munzenmaier, and A. S. Greene. Regulation of angiotensin II receptors in cremasteric microvessels by sodium intake. FASEB J. 10:A58, 1996.
Nora, E. H., D. H. Munzenmaier, F. M. Hansen-Smith, J. H. Lombard, and A. S. Greene. Localization of the angiotensin II type 2 receptor in the microcirculation of skeletal muscle. Am.J.Physiol. 275:H1395–H1403, 1998.
Ozono, R., Z. Wang, A. F. Moore, T. Inagami, H. M. Siragy, and R. M. Carey. Expression of the subtype 2 angiotensin (AT 2 ) receptor protein in rat kidney. Hypertension (Dallas) 30:1238–1246, 1997.
Pernollet, M.-G., M. A. Devynck, P. G. Matthews, and P. Meyer. Post-nephrectomy changes in adrenal angiotensin II receptors in the rat: Influence of exogenous angiotensin and a competitive inhibitor. Eur.J.Pharmaco. 43:361–372, 1977.
Raizada, M. K., M. I. Phillips, and C. Sumners. Cellular and Molecular Biology of the Renin-Angiotensin System. Boca Raton: CRC, 1993.
Rakugi, H., D. Wang, V. Dzau, and R. Pratt, Potential importance of tissue angiotensin-converting enzyme inhibition preventing neointima formation. Circulation 90:449–455, 1994.
Rieder, M. J., R. J. Roman, and A. S. Greene. Reversal of microvascular rarefaction and reduced renal mass hyperten-sion. Hypertension (Dallas) 30:120–127, 1997.
Riordan, J. F. Angiotensin II: Biosynthesis, molecular recog-nition, and signal transduction. Cell.Mol.Neurobiol. 15:637–651, 1995.
Sabri, A., B. I. Levy, P. Poitevin, L. Caputo, E. Faggin, F. Marotte, L. Rappaport, and J. L. Samuel. Differential roles of the AT 1 and AT 2 receptor subtypes in vascular trophic and phenotypic changes in response to stimulation with angio-tensin II. Arterioscler.Thromb.Vasc.Biol. 17:257–264, 1997.
Scheuer, D. A., and M. H. Perrone. Angiotensin type 2 receptors mediate the depressor phase of biphasic pressure response to angiotensin. Am.J.Physiol. 264:R917–R923, 1993.
Stoll, M., U. M. Steckelings, M. Paul, S. P. Bottari, R. Metzger, and T. Unger. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J.Clin.Invest. 95:651–657, 1995.
Unger, T., O. Chung, T. Csikos, J. Culman, S. Gallinat, P. Gohlke, S. Hohle, S. Meffert, M. Stoll, U. Stroth, and Y. Zhu. Angiotensin receptors. J.Hypertens. 14:S95–S103, 1996.
Viswanathan, M., M. K. Tsutsumi, F. M. A. Correa, and J. M. Saavedra. Changes in the expression of angiotensin re-ceptor subtypes in the rat aorta during development. Bio-chem.Biophys.Res.Commun. 179:1361–1367, 1991.
Wang, D. H., and R. L. Prewitt. Longitudinal effect of captopril on aortic and arteriolar development in normotensive animals. Am.J.Physiol. 260:H1959–H1965, 1991.
Weber, D. S., J. C. Frisbee, and J. H. Lombard. Selective potentiation of angiotensin-induced constriction of skeletal muscle resistance arteries by chronic elevations in dietary salt intake. Microvasc.Res. 57:310–319, 1999.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nora, E.H., Tonellato, P.J. & Greene, A.S. Quantification of the Contribution of Type 1 and Type 2 Angiotensin II Receptors to the Net Tissue Specific Effect of Angiotensin II. Annals of Biomedical Engineering 28, 653–664 (2000). https://doi.org/10.1114/1.1305911
Issue Date:
DOI: https://doi.org/10.1114/1.1305911